| |
| |
|
| Insider
Information: |
Pagan Douglas W. |
| Relationship: |
Chief Financial Officer |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
136,750 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$230,860 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
136,750 |
|
|
| Total
Value |
$230,860 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Paratek Pharmaceuticals Inc |
PRTK |
Chief Financial Officer |
2019-04-05 |
100,807 |
2016-02-04 |
0 |
Premium* |
|
|
Alaunos Therapeutics |
TCRT |
Director |
2019-12-31 |
35,943 |
2018-12-31 |
0 |
Premium* |
|
|
Dicerna Pharmaceuticals Inc |
DRNA |
Chief Financial Officer |
2021-12-28 |
0 |
2021-06-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2021-12-28 |
4 |
D |
$38.25 |
$297,394 |
D/D |
(7,775) |
0 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2021-12-15 |
4 |
D |
$38.05 |
$22,906 |
D/D |
(602) |
7,775 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2021-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,050 |
8,377 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2021-06-15 |
4 |
D |
$35.74 |
$71,623 |
D/D |
(2,004) |
5,760 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2021-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,825 |
7,764 |
0 |
- |
|
| TCRT |
Alaunos Therapeutics |
Director |
– • – |
2019-12-31 |
4 |
D |
$4.72 |
$94,655 |
D/D |
(20,054) |
35,943 |
0 |
- |
|
| TCRT |
Alaunos Therapeutics |
Director |
– • – |
2019-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
15,890 |
55,997 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2019-04-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(100,250) |
70,807 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2019-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
100,807 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2019-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
37,000 |
171,057 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2019-02-05 |
4 |
AS |
$6.77 |
$16,891 |
D/D |
(2,495) |
134,057 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2019-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
16,250 |
136,552 |
0 |
- |
|
| TCRT |
Alaunos Therapeutics |
Director |
– • – |
2018-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
40,107 |
40,107 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2018-12-12 |
4 |
AS |
$6.76 |
$19,726 |
D/D |
(2,918) |
120,302 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2018-10-15 |
4 |
AS |
$8.96 |
$24,945 |
D/D |
(2,784) |
123,220 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2018-10-12 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
126,004 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2018-10-03 |
4 |
AS |
$9.82 |
$74,426 |
D/D |
(7,579) |
119,504 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2018-10-02 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
127,083 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2018-04-09 |
4 |
AS |
$12.70 |
$66,510 |
D/D |
(5,237) |
77,083 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2018-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
13,500 |
82,320 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2018-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
29,250 |
68,820 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2018-02-05 |
4 |
AS |
$14.22 |
$231,658 |
D/D |
(16,291) |
39,570 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2017-07-05 |
4 |
AS |
$23.58 |
$97,593 |
D/D |
(4,139) |
55,861 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2017-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
60,000 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2017-06-19 |
4 |
AS |
$25.00 |
$114,875 |
D/D |
(4,595) |
51,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
